GATA3 and Alzheimer disease: However, treatments with prebiotics (T1~T3) induced a significant decrease in the mRNA expression of Th2- specific transcription factor GATA3 and cytokine IL-4, which were increased in the DNCB-induced AD control (N) (Fig 2B).